FORBION CAPITAL PARTNERS
Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion's investment team of nine investment professionals has built an impressive performance track record since the late nineties with successful investments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed €400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.
FORBION CAPITAL PARTNERS
Social Links:
Industry:
Biotechnology Health Care Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
+31 35 699 30 00
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Google Maps
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Polaris Partners
Polaris Partners is an investment firm that invests in healthcare and biotechnology companies.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-04 | F2G | Forbion Capital Partners investment in Private Equity Round - F2G | 70 M USD |
| 2022-06-29 | VectivBio | Forbion Capital Partners investment in Post-IPO Equity - VectivBio | 54 M USD |
| 2022-03-16 | Precirix | Forbion Capital Partners investment in Series B - Precirix | 80 M EUR |
| 2022-02-23 | Complement Therapeutics | Forbion Capital Partners investment in Seed Round - Complement Therapeutics | 5 M EUR |
| 2021-12-20 | ARMGO,Pharma,Inc. | Forbion Capital Partners investment in Series B - ARMGO,Pharma,Inc. | 35 M USD |
| 2021-12-17 | NorthSea Therapeutics | Forbion Capital Partners investment in Series C - NorthSea Therapeutics | 80 M USD |
| 2021-12-16 | Anaveon | Forbion Capital Partners investment in Series B - Anaveon | 110 M CHF |
| 2021-11-03 | Prilenia | Forbion Capital Partners investment in Series B - Prilenia | 43 M USD |
| 2021-10-14 | Rectify Pharmaceuticals | Forbion Capital Partners investment in Series A - Rectify Pharmaceuticals | 100 M USD |
| 2021-07-07 | NeRRe Therapeutics | Forbion Capital Partners investment in Series B - NeRRe Therapeutics | 20 M GBP |
More informations about "Forbion Capital Partners"
Forbion
Melanie is an Associate and joined the Forbion investment team in September 2022 as an intern after receiving her Ph.D in Oncology from the University of Vienna. ... Sander is Managing …See details»
About us - Forbion
Forbion then and now. Forbion was born out of ABN AMRO Capital Life Sciences. Today, to emphasize its value-add beyond merely providing capital, we are simply known as Forbion.For more than two decades, our investment team has built …See details»
Forbion Capital Partners - Crunchbase
Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion's investment team of nine …See details»
Forbion - LinkedIn
Forbion | 14,251 followers on LinkedIn. Impacting the future of medicine | Forbion was born out of ABN AMRO Capital Life Sciences in 2000. Six years later, we transitioned to Forbion Capital …See details»
Forbion's €2B funds are largest yet, with 30 biotechs to benefit
Oct 15, 2024 Netherlands- and Germany-based Forbion exceeded its targets for its two newest funds, Forbion Growth Opportunities III and Forbion Ventures VII, by bringing in 1.2 billion …See details»
Forbion Capital Partners. (10/15/24). "Press Release: Forbion …
Forbion has 58 active investments, and has led or co-led 88% of the initial investment rounds of the 26 portfolio companies across Forbion Growth Opportunities Fund II and Forbion Ventures …See details»
Forbion Capital Partners - Company Profile and News
Forbion Capital Partners operates as a venture capital firm. The Company invests in life sciences and biomedical technology companies, as well as offers investment management services.See details»
Forbion Capital Partners - Investments, Portfolio & Company Exits
Forbion Capital Partners has made 6 diversity investments. Their most recent diversity investment was on Dec 20, 2021, when ARMGO Pharma raised. obfuscated. obfuscated. Announced …See details»
Forbion Capital Partners Portfolio Companies - Crunchbase
Jan 2, 2011 Forbion Capital Partners is a private equity and venture capital firm for making investments in buyouts. This list of organizations invested in by Forbion Capital Partners …See details»
Forbion Capital Partners - EU-Startups
Forbion is a leading European venture capital firm that helps companies bridge research and development through the team’s expertise in drug development and company building. …See details»
AMG Announces Partnership with Forbion
Jun 27, 2023 Forbion is a leading pan-European venture capital and growth equity firm focused on investing in high-quality life sciences companies across all stages of their development. …See details»
Forbion Capital Partners. (8/17/23). "Press Release: AMG …
Forbion is a leading pan-European venture capital and growth equity firm focused on investing in high-quality life sciences companies across all stages of their development. With …See details»
Forbion raises €1.35 billion across two funds - Yahoo Finance
Forbion’s largest fundraising to date€750 million raised in the final close of the Forbion Ventures Fund VI €600 million raised in the final close of the Forbion Growth Opportunities Fund II ...See details»
Portfolio - Forbion
The Forbion European Acquisition Corporation (FEAC) is an entity integrated into the Forbion Growth Fund and is fully part of the fund’s portfolio. ... Forbion Capital Partners co-led …See details»
Forbion Capital Partners - Funding, Financials, Valuation & Investors
Forbion Capital Partners . Connect to CRM . Save . Summary. Financials. Investments. People. Technology. Signals & News. Similar Companies. Highlights. Funds 12. Funding. Forbion …See details»
Forbion announces first close of Forbion Growth Opportunities …
Jun 9, 2022 Forbion expects to reach its €600 million hard cap, completing the raising of Forbion Growth Opportunities Fund II over the summer. Sander Slootweg, Managing Partner and co …See details»
Forbion raises in excess of €2 billion for two new funds
Oct 15, 2024 Naarden, The Netherlands, October 15, 2024 – Forbion, a leading global life sciences venture capital firm with deep expertise in Europe, today announces that it has raised …See details»
Forbion Capital Partners - Contacts, Employees, Board
Forbion Capital Partners has 17 current employee profiles, including Partner Rogier Rooswinkel. Forbion Capital Partners has 2 board members and advisors, including Kapil Dhingra. …See details»
Forbion Capital Partners. (12/9/21). "Press Release: Forbion …
Forbion European Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 11,000,000 units at a price of $10.00 per unit. The units are expected to be …See details»
Forbion Growth Opportunities Fund
Forbion Growth Opportunities I (FGO I) Fund size: €360m 10-12 investments The first Forbion Growth Opportunities Fund (FGO I) was launched in 2021 with its final close in Q1 2021 at …See details»